Anteris Technologies Global Corp. income statement
In fiscal 2025, Anteris Technologies Global Corp. reported revenue of $1.9m, down 29.2% on the year before, operating income of −$93.9m (a -4908.2% margin) and net income of −$94.1m, or −$2.55 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.
Income statement
| Fiscal year | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|
| Revenue | 3 | 2 | 2 |
| Cost of revenue | 1 | 1 | 1 |
| Gross profit | 1 | 1 | 2 |
| Research and development | 51 | 69 | 77 |
| Selling, general and administrative | 28 | 26 | 31 |
| Operating income | −78 | −94 | −106 |
| Interest expense | 0 | 0 | 0 |
| Income before tax | −76 | −94 | −102 |
| Income tax | 0 | 0 | 0 |
| Net income | −76 | −94 | −104 |
| Diluted EPS | −$3.68 | −$2.55 | −$1.62 |
| Diluted shares (average) | 20m | 37m | 64m |
| EBITDA | −77 | −92 | −104 |
| Quarter | 2024 Q3Sept 2024 | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 1 |
| Cost of revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Research and development | 14 | 13 | 16 | 16 | 17 | 20 | 17 | 23 |
| Selling, general and administrative | 7 | 9 | 6 | 5 | 6 | 10 | 7 | 8 |
| Operating income | −21 | −22 | −22 | −21 | −22 | −29 | −24 | −31 |
| Interest expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income before tax | −22 | −19 | −22 | −21 | −22 | −29 | −22 | −29 |
| Income tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income | −22 | −19 | −22 | −21 | −22 | −29 | −23 | −29 |
| Diluted EPS | −$0.54 | −$0.35 | −$0.30 | −$0.29 | −$0.31 | −$0.38 | −$0.28 | −$0.30 |
| EBITDA | −20 | −21 | −21 | −20 | −22 | −29 | −24 | −31 |
Compare with peers
- Femasys Inc income statement
- Volitionrx LTD income statement
- Seastar Medical Holding Corp income statement
- Insight Molecular Diagnostics Inc. income statement
- Icecure Medical Ltd. income statement
Head to head: AVR vs FEMYAVR vs VNRXAVR vs ICU
More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies